There were 803 press releases posted in the last 24 hours and 358,088 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Aeglea BioTherapeutics Receives FDA Fast Track Designation for AEB1102 for the Treatment of Patients with Hyperargininemia Secondary to Arginase I Deficiency

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image